Quantcast

Global Molecular Biology Enzymes, Kits, and Reagents Markets, 2018-2019 & 2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Molecular Biology Enzymes, Kits, and Reagents Market 2019-2023”

report has been added to ResearchAndMarkets.com’s
offering.

The molecular biology enzymes, kits, and reagents market will register a
CAGR of 16% by 2023.

The rising incidence of infectious diseases and genetic disorders will
drive the market growth in the forecast period. Incidences of infections
caused by pathogens including bacteria, fungi, viruses, and parasites
are likely to contribute to the surging incidences of bladder infections
and urinary tract infections. In addition, researchers are increasingly
focusing on molecular biology for treating diseases using gene therapy
and recombinant vaccines. This will further lead the molecular biology
enzymes, kits, and reagents market growth during the forecast period.

Market Overview

Increased use of proteins and reagents in biotechnology and
pharmaceutical companies

One of the growth drivers of the global molecular biology enzymes, kits,
and reagents market is the increased use of proteins and reagents in
biotechnology and pharmaceutical companies. The increased use of
proteins and reagents in biotechnology and pharmaceutical companies for
applications such as drug discovery and development and in molecular
biology research has propelled the growth of the market.

High costs and lack of reimbursement policies for genetic testing

One of the challenges in the growth of the global molecular biology
enzymes, kits, and reagents market is the high costs and lack of
reimbursement policies for genetic testing. The expensive nature of
genetic tests leads to their decreased adoption among individuals,
thereby reducing the overall demand for molecular biology enzymes, kits,
and reagents necessary to perform these tests.

Competitive Landscape

The market appears to be moderately fragmented with the presence of
several market players. Vendors in the market are focusing on offering a
portfolio of diagnostic assays to hospitals, community clinics,
pathology laboratories, and immunology laboratories for diagnosis of
patients, pathogen detection, and viral load monitoring. This market
research report will help clients identify new growth opportunities and
design unique growth strategies by providing a comprehensive analysis of
the market’s competitive landscape and offering information on the
products offered by companies.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Biotechnology and pharmaceutical companies – Market size and forecast
    2018-2023
  • Hospitals and diagnostic centers – Market size and forecast 2018-2023
  • Academic institutes and research organizations – Market size and
    forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2018-2023
  • Europe – Market size and forecast 2018-2023
  • Asia – Market size and forecast 2018-2023
  • ROW – Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Rising use of molecular biology kits for disease diagnosis
  • Increasing number of applications of molecular biology
    enzymes,
    kits, and reagents
  • Technological advances in the life sciences industry

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/r/8jxl0v

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Enzymes

Read the full article

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.